|
|
Volumn 210, Issue 9, 2010, Pages 468-
|
|
Blood pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: A randomised, double-blind, placebo-controlled, active comparative study;Reducción de la presión arterial con LCZ696, un nuevo inibidor del receptor ii de la angiotensina y de la neprilisina, de doble acción: estudio randomizado, doble ciego, con control placebo y comparador activo
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AHU 377;
ANGIOTENSIN II ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
ENZYME INHIBITOR;
LCZ 696;
MEMBRANE METALLOENDOPEPTIDASE;
UNCLASSIFIED DRUG;
VALSARTAN;
ARTERIAL PRESSURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DIASTOLIC BLOOD PRESSURE;
DRUG ACTIVITY;
DRUG MECHANISM;
HUMAN;
HYPERTENSION;
MAJOR CLINICAL STUDY;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
|
|
EID: 77957598328
PISSN: 00142565
EISSN: 15781860
Source Type: Journal
DOI: 10.1016/j.rce.2010.04.017 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
